Substance use disorders: Psychoneuroimmunological mechanisms and new targets for therapy

Comorbidity of Mental Disorders With Alcohol and Other Drug Abuse: Results From the Epidemiologic Catchment Area (ECA) Study

Regier, D. A. (1990) · JAMA · doi:10.1001/jama.1990.03450190043026 · Cited by 3,962 · see citing works

Drug Dependence, a Chronic Medical Illness

McLellan, A. T., Lewis, D. C., O'Brien, C. P., & Kleber, H. D. (2000) · JAMA · doi:10.1001/jama.284.13.1689 · Cited by 2,622 · cited 1× · see citing works

Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials

Gupta, S. C., Patchva, S., & Aggarwal, B. B. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9432-8 · Cited by 2,124 · see citing works

Effectiveness of brief alcohol interventions in primary care populations

Kaner, E. F., Beyer, F. R., Muirhead, C., Campbell, F., Pienaar, E. D., Bertholet, N., Daeppen, J. B., Saunders, J. B., & Burnand, B. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004148.pub4 · Cited by 1,665 · see citing works

Evolving epidemiology of hepatitis C virus

Lavanchy, D. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03432.x · Cited by 1,318 · see citing works

The Relationship of Depression and Stressors to Immunological Assays: A Meta-Analytic Review

Zorrilla, E. P., Luborsky, L., McKay, J. R., Rosenthal, R., Houldin, A., Tax, A., McCorkle, R., Seligman, D. A., & Schmidt, K. (2001) · Brain, Behavior, and Immunity · doi:10.1006/brbi.2000.0597 · Cited by 995 · see citing works

Depression and immunity: A meta-analytic review.

Herbert, T. B., & Cohen, S. (1993) · Psychological Bulletin · doi:10.1037/0033-2909.113.3.472 · Cited by 812 · see citing works

Prevalence, correlates, and course of minor depression and major depression in the National Comorbidity Survey

Kessler, R. C., Zhao, S., Blazer, D. G., & Swartz, M. (1997) · Journal of Affective Disorders · doi:10.1016/s0165-0327(97)00056-6 · Cited by 790 · see citing works

Loss of Dopamine Transporters in Methamphetamine Abusers Recovers with Protracted Abstinence

Volkow, N. D., Chang, L. L., Wang, G., Fowler, J. S., Franceschi, D., Sedler, M. J., Gatley, S. J., Miller, E. N., HITZEMANN, R. J., Ding, Y., et al. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-23-09414.2001 · Cited by 754 · see citing works

Effectiveness of brief alcohol interventions in primary care populations

Kaner, E. F. S., Dickinson, H. O., Beyer, F. R., Campbell, F., Schlesinger, C., Heather, N., Saunders, J. B., Burnand, B., & Pienaar, E. D. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004148.pub3 · Cited by 746 · see citing works

Oral topiramate for treatment of alcohol dependence: A randomised controlled trial

Johnson, B. A., Ait-Daoud, N., Bowden, C. L., DiClemente, C. C., Roache, J. D., Lawson, K., Javors, M. A., & Ma, J. Z. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13370-3 · Cited by 743 · see citing works

Behavioral Counseling Interventions in Primary Care To Reduce Risky/Harmful Alcohol Use by Adults: A Summary of the Evidence for the U.S. Preventive Services Task Force

Whitlock, E. P., Polen, M. R., Green, C. A., Orleans, T., & Klein, J. D. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-7-200404060-00017 · Cited by 711 · see citing works

Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials

Krebs, T. S., & Johansen, P.-Ø. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112439253 · Cited by 583 · see citing works

Suggestive Evidence for Receptors for Morphine and Methionine-Enkephalin on Normal Human Blood T Lymphocytes

Wybran, J., Appelboom, T., Famaey, J.-P., & Govaerts, A. (1979) · The Journal of Immunology · doi:10.4049/jimmunol.123.3.1068 · Cited by 580 · see citing works

Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients

Khoruts, A., Stahnke, L., McClain, C. J., Logan, G., & Allen, J. I. (1991) · Hepatology · doi:10.1002/hep.1840130211 · Cited by 549 · see citing works

Topiramate for Treating Alcohol Dependence<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>

Johnson, B. A. (2007) · JAMA · doi:10.1001/jama.298.14.1641 · Cited by 542 · see citing works

Alcohol and Immune Defense

MacGregor, R. R. (1986) · JAMA · doi:10.1001/jama.1986.03380110080031 · Cited by 428 · see citing works

Aspirin: a review of its neurobiological properties and therapeutic potential for mental illness

Berk, M., Dean, O. M., Drexhage, H. A., McNeil, J. J., Moylan, S., O'Neil, A. E., Davey, C. G., Sanna, L., & Maes, M. H. J. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-74 · Cited by 392 · see citing works

Opioid Therapy and Immunosuppression

Vallejo, R., de León-Casasola, O. A., & Benyamin, R. M. (2004) · American Journal of Therapeutics · doi:10.1097/01.mjt.0000132250.95650.85 · Cited by 385 · see citing works

Methamphetamine causes microglial activation in the brains of human abusers

Sekine, Y., Ouchi, Y., Sugihara, G., Takei, N., Yoshikawa, E., Nakamura, K., Iwata, Y., Tsuchiya, K. J., Suda, S., Suzuki, K., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.1179-08.2008 · Cited by 381 · see citing works

Mindfulness meditation for substance use disorders: a systematic review

Zgierska, A., Rabago, D., Chawla, N., Kushner, K., Koehler, R., & Marlatt, A. (2009) · Substance Abuse · doi:10.1080/08897070903250019 · Cited by 348 · see citing works

Morphine induces apoptosis of human microglia and neurons

Hu, S., Sheng, W. S., Lokensgard, J. R., & Peterson, P. K. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00030-8 · Cited by 328 · see citing works

Methamphetamine Neurotoxicity in Dopamine Nerve Endings of the Striatum Is Associated with Microglial Activation

Thomas, D. M., Walker, P. D., Benjamins, J. A., Geddes, T. J., & Kuhn, D. M. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.070961 · Cited by 315 · see citing works

Role of intestinal permeability and inflammation in the biological and behavioral control of alcohol-dependent subjects

Leclercq, S., Cani, P. D., Neyrinck, A. M., Stärkel, P., Jamar, F., Mikolajczak, M., Delzenne, N. M., & de Timary, P. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.04.001 · Cited by 310 · see citing works

Immunologic Dysfunction in Heroin Addicts

Brown, S. M. (1974) · Archives of Internal Medicine · doi:10.1001/archinte.1974.00320240035003 · Cited by 296 · see citing works

High Mobility Group Box 1/Toll-like Receptor Danger Signaling Increases Brain Neuroimmune Activation in Alcohol Dependence

Crews, F. T., Qin, L., Sheedy, D. L., Vetreno, R. P., & Zou, J. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.09.030 · Cited by 295 · see citing works

Dialectical Behavior Therapy for Substance Abusers

Dimeff, L. A. (2008) · Addiction Science & Clinical Practice · doi:10.1151/ascp084239 · Cited by 285 · see citing works

The Periaqueductal Gray Matter Mediates Opiate-Induced Immunosuppression

Weber, R. J., & Pert, A. (1989) · Science · doi:10.1126/science.2749256 · Cited by 281 · see citing works

Substance Use Disorders in Schizophrenia--Clinical Implications of Comorbidity

Volkow, N. D. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp016 · Cited by 272 · see citing works

Effects of Methamphetamine Dependence and HIV Infection on Cerebral Morphology

Jernigan, T. L., Gamst, A. C., Archibald, S. L., Fennema‐Notestine, C., Mindt, M. R., Marcotte, T. D., Heaton, R. K., Ellis, R. J., & Grant, I. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.8.1461 · Cited by 269 · see citing works

Opioid modulation of immune responses: effects on phagocyte and lymphoid cell populations

Eisenstein, T. K., & Hilburger, M. E. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00219-1 · Cited by 263 · see citing works

Current Status of Co-Occurring Mood and Substance Use Disorders: A New Therapeutic Target

Pettinati, H. M., O’Brien, C. P., & Dundon, W. D. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12010112 · Cited by 254 · see citing works

Neuroimmune regulation of alcohol consumption: behavioral validation of genes obtained from genomic studies

Blednov, Y. A., Ponomarev, I., Geil, C., Bergeson, S., Koob, G. F., & Harris, R. A. (2012) · Addiction Biology · doi:10.1111/j.1369-1600.2010.00284.x · Cited by 251 · see citing works

The Effects of Postoperative Pain Management on Immune Response to Surgery

Beilin, B., Shavit, Y., Trabekin, E., Mordashev, B., Mayburd, E., Zeidel, A., & Bessler, H. (2003) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000078586.82810.3b · Cited by 250 · see citing works

Marijuana and Cocaine Impair Alveolar Macrophage Function and Cytokine Production

Baldwin, G. C., Tashkin, D. P., Buckley, D. M., PARK, A. N., Dubinett, S. M., & Roth, M. D. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.5.9704146 · Cited by 230 · see citing works

Update on harm-reduction policy and intervention research

Marlatt, G. A., & Witkiewitz, K. (2010) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.121208.131438 · Cited by 220 · cited 1× · see citing works

Evolving Epidemiology of Hepatitis C Virus in the United States

Klevens, R. M., Hu, D. J., Jiles, R., & Holmberg, S. D. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis393 · Cited by 214 · see citing works

Impact of TLR4 on behavioral and cognitive dysfunctions associated with alcohol-induced neuroinflammatory damage

Pascual, M., Baliño, P., Alfonso-Loeches, S., Aragón, C. M. G., & Guerri, C. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.02.012 · Cited by 213 · see citing works

A Role for Cognitive Rehabilitation in Increasing the Effectiveness of Treatment for Alcohol Use Disorders

Bates, M. E., Buckman, J. F., & Nguyen, T. T. T. (2013) · Neuropsychology Review · doi:10.1007/s11065-013-9228-3 · Cited by 211 · see citing works

Enlarged striatum in abstinent methamphetamine abusers: A possible compensatory response

Chang, L., Cloak, C. C., Patterson, K., Grob, C. S., Miller, E. N., & Ernst, T. M. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.039 · Cited by 206 · see citing works

Medications development to treat alcohol dependence: a vision for the next decade

Litten, R. Z., Egli, M., Heilig, M. A., Cui, C., Fertig, J. B., Ryan, M. L., Falk, D. E., Moss, H. B., Huebner, R. B., & Noronha, A. (2012) · Addiction Biology · doi:10.1111/j.1369-1600.2012.00454.x · Cited by 204 · see citing works

Early-life experience decreases drug-induced reinstatement of morphine CPP in adulthood via microglial-specific epigenetic programming of anti-inflammatory IL-10 expression

Schwarz, J. M., Hutchinson, M. R., & Bilbo, S. D. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3297-11.2011 · Cited by 203 · see citing works

Harm reduction therapy: a practice‐friendly review of research

Logan, D. E., & Marlatt, G. A. (2010) · Journal of Clinical Psychology · doi:10.1002/jclp.20669 · Cited by 192 · see citing works

Implications of central immune signaling caused by drugs of abuse: Mechanisms, mediators and new therapeutic approaches for prediction and treatment of drug dependence

Coller, J. K., & Hutchinson, M. R. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.01.008 · Cited by 186 · see citing works

Differential effects of polyphenols and alcohol of red wine on the expression of adhesion molecules and inflammatory cytokines related to atherosclerosis: a randomized clinical trial

Chiva‐Blanch, G., Urpí-Sardà, M., Llorach, R., Rotchés-Ribalta, M., Guillén, M., Casas, R. M., Arranz, S., Valderas-Martínez, P., Portolés, O., Corella, D., et al. (2011) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.022889 · Cited by 183 · see citing works

The Effects of Psychostimulant Drugs on Blood Brain Barrier Function and Neuroinflammation

Kousik, S. M., Napier, T. C., & Carvey, P. M. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00121 · Cited by 175 · see citing works

The Role of Oxidative Stress, Metabolic Compromise, and Inflammation in Neuronal Injury Produced by Amphetamine-Related Drugs of Abuse

Yamamoto, B. K., & Raudensky, J. (2008) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-008-9121-7 · Cited by 167 · see citing works

Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients.

Novick, D. M., Ochshorn, M., Ghali, V., Croxson, T. S., Mercer, W. D., Chiorazzi, N., & Kreek, M. J. (1989) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22252-2 · Cited by 167 · see citing works

Psychostimulant abuse and neuroinflammation: emerging evidence of their interconnection.

Clark, K. H., Wiley, C. A., & Bradberry, C. W. (2013) · Neurotoxicity Research · doi:10.1007/s12640-012-9334-7 · Cited by 165 · see citing works

Addiction treatment services and co-occurring disorders: Prevalence estimates, treatment practices, and barriers

McGovern, M. P., Xie, H., Segal, S. R., Siembab, L., & Drake, R. E. (2006) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2006.05.003 · Cited by 164 · see citing works

Impaired Emotional-Like Behavior and Serotonergic Function During Protracted Abstinence from Chronic Morphine

Goeldner, C., Lutz, P.-E., Darcq, E., Halter, T., Clesse, D., Ouagazzal, A.-M., & Kieffer, B. L. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.08.021 · Cited by 163 · see citing works

Protective effects of minocycline on behavioral changes and neurotoxicity in mice after administration of methamphetamine

Zhang, L., Kitaichi, K., Fujimoto, Y., Nakayama, H., Shimizu, E., Iyo, M., & Hashimoto, K. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.05.015 · Cited by 159 · see citing works

Cognitive enhancement as a pharmacotherapy target for stimulant addiction

Sofuoglu, M. (2009) · Addiction · doi:10.1111/j.1360-0443.2009.02791.x · Cited by 158 · see citing works

Activated microglia are implicated in cognitive deficits, neuronal death, and successful recovery following intermittent ethanol exposure

Zhao, Y., Wang, F., Fan, Y., Ping, G.-F., Yang, J., & Wu, C. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.08.052 · Cited by 153 · see citing works

Global use of alcohol, drugs and tobacco

ANDERSON, P. (2006) · Drug and Alcohol Review · doi:10.1080/09595230600944446 · Cited by 151 · see citing works

Methamphetamine Inhibits Antigen Processing, Presentation, and Phagocytosis

Tallóczy, Z., Martínez, J., Joset, D., Ray, Y., Gácser, A., Toussi, S., Mizushima, N., Nosanchuk, J., Goldstein, H., Loike, J., et al. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.0040028 · Cited by 147 · see citing works

Methamphetamine Enhances HIV Infection of Macrophages

Liang, H., Wang, X., Chen, H., Li, S., Ye, L., Wang, S.-H., Wang, Y., Zhou, L., & Ho, W. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.070971 · Cited by 147 · see citing works

Inflammation and neurological disease-related genes are differentially expressed in depressed patients with mood disorders and correlate with morphometric and functional imaging abnormalities

Savitz, J., Frank, M. B., Victor, T., Bebak, M., Marino, J. H., Bellgowan, P. S. F., McKinney, B. A., Bodurka, J., Kent Teague, T., & Drevets, W. C. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.10.007 · Cited by 146 · see citing works

Abstinence following Alcohol Drinking Produces Depression-Like Behavior and Reduced Hippocampal Neurogenesis in Mice

Stevenson, J. R., Schroeder, J. P., Nixon, K., Besheer, J., Crews, F. T., & Hodge, C. W. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.90 · Cited by 145 · see citing works

Methamphetamine Causes Persistent Immune Dysregulation: A Cross-Species, Translational Report

Loftis, J. M., Choi, D., Hoffman, W. F., & Huckans, M. S. (2010) · Neurotoxicity Research · doi:10.1007/s12640-010-9223-x · Cited by 141 · see citing works

Immune system inflammation in cocaine dependent individuals: implications for medications development.

Fox, H. C., D'Sa, C., Kimmerling, A., Siedlarz, K. M., Tuit, K. L., Stowe, R., & Sinha, R. (2012) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.1251 · Cited by 140 · see citing works

Randomized Trial of Long-Acting Sustained-Release Naltrexone Implant vs Oral Naltrexone or Placebo for Preventing Relapse to Opioid Dependence

Krupitsky, E., Zvartau, E., Blokhina, E., Verbitskaya, E., Wahlgren, V., Tsoy-Podosenin, M., Bushara, N., Burakov, A., Masalov, D., Romanova, T., et al. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2012.1a · Cited by 138 · see citing works

Medication discovery for addiction: Translating the dopamine D3 receptor hypothesis

Newman, A. H., Blaylock, B. L., Nader, M. A., Bergman, J., Sibley, D. R., & Skolnick, P. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.06.023 · Cited by 134 · see citing works

Minocycline: Therapeutic Potential in Psychiatry

Dean, O. M., Data-Franco, J., Giorlando, F., & Berk, M. (2012) · CNS Drugs · doi:10.2165/11632000-000000000-00000 · Cited by 131 · see citing works

Involvement of metabotropic glutamate receptor 5, AKT/PI3K Signaling and NF-κB pathway in methamphetamine-mediated increase in IL-6 and IL-8 expression in astrocytes

Shah, A. B., Silverstein, P. S., Singh, D. P., & Kumar, A. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-52 · Cited by 128 · see citing works

Therapeutic mechanisms of classic hallucinogens in the treatment of addictions: from indirect evidence to testable hypotheses

Bogenschutz, M. P., & Pommy, J. M. (2012) · Drug Testing and Analysis · doi:10.1002/dta.1376 · Cited by 125 · see citing works

The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: biological correlates of disease

Letendre, S. L., Cherner, M., Ellis, R. J., Marquie‐Beck, J., Gragg, B., Marcotte, T. D., Heaton, R. K., McCutchan, J. A., & Grant, I. (2005) · AIDS · doi:10.1097/01.aids.0000192073.18691.ff · Cited by 122 · see citing works

Toll‐like receptor 4 participates in the myelin disruptions associated with chronic alcohol abuse

Alfonso‐Loeches, S., Pascual, M., Gómez‐Pinedo, U., Pascual‐Lucas, M., Renau‐Piqueras, J., & Guerri, C. (2012) · Glia · doi:10.1002/glia.22327 · Cited by 117 · see citing works

Managing the adverse effects of nonsteroidal anti-inflammatory drugs

Patrignani, P., Tacconelli, S., Bruno, A., Sostres, C., & Lanas, Á. (2011) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.11.36 · Cited by 117 · see citing works

Depressive symptoms in patients with chronic hepatitis C are correlated with elevated plasma levels of interleukin-1β and tumor necrosis factor-α

Loftis, J. M., Huckans, M. S., Ruimy, S., Hinrichs, D. J., & Hauser, P. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.11.001 · Cited by 117 · see citing works

Alterations of Immune Functions in Heroin Addicts and Heroin Withdrawal Subjects

Govitrapong, P., Suttitum, T., Kotchabhakdi, N., & Uneklabh, T. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37665-7 · Cited by 113 · see citing works

Repeated Lipopolysaccharide (LPS) or Cytokine Treatments Sensitize Ethanol Withdrawal-Induced Anxiety-Like Behavior

Breese, G. R., Knapp, D. J., Overstreet, D. H., Navarro, M., Wills, T. A., & Angel, R. A. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301468 · Cited by 110 · see citing works

Vaccines Against Drug Abuse

Shen, X. Y., Orson, F. M., & Kosten, T. R. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.281 · Cited by 110 · see citing works

Disordered Sleep, Nocturnal Cytokines, and Immunity in Alcoholics

Redwine, L., Dang, J., Hall, M., & Irwin, M. (2003) · Psychosomatic Medicine · doi:10.1097/01.psy.0000038943.33335.d2 · Cited by 109 · see citing works

Co‐Morbidity of Lifetime Psychiatric Disorder Among Male Alcoholic Patients

Penick, E. C., Powell, B. J., Nickel, E. J., Bingham, S. F., Riesenmy, K. R., Read, M. R., & Campbell, J. L. (1994) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1994.tb01425.x · Cited by 106 · see citing works

Anti-inflammatory role of naringenin in rats with ethanol induced liver injury

Jayaraman, J., Jesudoss, V. A. S., Menon, V. P., & Nalini, N. (2012) · Toxicology Mechanisms and Methods · doi:10.3109/15376516.2012.707255 · Cited by 103 · see citing works

Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antibiotic drug minocycline

Fujita, Y., Ishima, T., Kunitachi, S., Hagiwara, H., Zhang, L., Iyo, M., & Hashimoto, K. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.08.031 · Cited by 99 · see citing works

Naltrexone Implant for the Treatment of Polydrug Dependence: A Randomized Controlled Trial

Tiihonen, J., Krupitsky, E. M., Verbitskaya, E. V., Blokhina, E. A., Mamontova, O., Föhr, J., Tuomola, P., Kuoppasalmi, K. I., Kiviniemi, V. V., & Zvartau, E. E. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11071121 · Cited by 98 · see citing works

Cocaine Hijacks σ1 Receptor to Initiate Induction of Activated Leukocyte Cell Adhesion Molecule: Implication for Increased Monocyte Adhesion and Migration in the CNS

Yao, H., Kim, K., Duan, M., Hayashi, T., Guo, M., Morgello, S., Prat, A., Wang, J., Su, T., & Buch, S. J. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.5618-10.2011 · Cited by 93 · see citing works

In vivo effects of cocaine on immune cell function

Pellegrino, T. C., & Bayer, B. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00230-0 · Cited by 93 · see citing works

Improvement by minocycline of methamphetamine-induced impairment of recognition memory in mice

Mizoguchi, H., Takuma, K., Fukakusa, A., Ito, Y., Nakatani, A., Ibi, D., Kim, H., & Yamada, K. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0955-0 · Cited by 92 · see citing works

Cocaine Dependence and Acute Cocaine Induce Decreases of Monocyte Proinflammatory Cytokine Expression across the Diurnal Period: Autonomic Mechanisms

Irwin, M. R., Olmos, L., Wang, M., Valladares, E. M., Motivala, S. J., Fong, T., Newton, T., Butch, A. W., Olmstead, R., & Cole, S. W. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.112797 · Cited by 88 · see citing works

Recombinant TCR Ligand Induces Tolerance to Myelin Oligodendrocyte Glycoprotein 35-55 Peptide and Reverses Clinical and Histological Signs of Chronic Experimental Autoimmune Encephalomyelitis in HLA-DR2 Transgenic Mice

Vandenbark, A. A., Rich, C. M., Mooney, J., Zamora, A., Wang, C., Huan, J., Fugger, L. H., Offner, H., Jones, R. E., & Burrows, G. G. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.1.127 · Cited by 88 · see citing works

Mechanisms of Suppression of Cellular Immunity Induced by Ethanol

Jerrells, T. R., Peritt, D., Marietta, C. A., & Eckardt, M. J. (1989) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1989.tb00363.x · Cited by 86 · see citing works

Psychiatric and Substance Use Disorders in Individuals with Hepatitis C: Epidemiology and Management

Loftis, J. M., Matthews, A. M., & Hauser, P. (2006) · Drugs · doi:10.2165/00003495-200666020-00003 · Cited by 86 · see citing works

Protein Phosphorylation Cascades Associated with Methamphetamine‐induced Glial Activation

Hebert, M. A., & O'Callaghan, J. P. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05200.x · Cited by 84 · see citing works

Gene Expression in Brain and Liver Produced by Three Different Regimens of Alcohol Consumption in Mice: Comparison with Immune Activation

Osterndorff-Kahanek, E. A., Ponomarev, I., Blednov, Y. A., & Harris, R. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059870 · Cited by 82 · see citing works

Insulin Resistance, Ceramide Accumulation and Endoplasmic Reticulum Stress in Experimental Chronic Alcohol-Induced Steatohepatitis

Ramirez, T., Longato, L., Dostálek, M., Tong, M., Wands, J. R., & de la Monte, S. M. (2012) · Alcohol and Alcoholism · doi:10.1093/alcalc/ags106 · Cited by 82 · see citing works

The unfolding web of innate immune dysregulation in alcoholic liver injury

Szabo, G., Mandrekar, P., Petrasek, J., & Catalano, D. (2011) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2010.01398.x · Cited by 82 · see citing works

Activation of p38 signaling in the microglia in the nucleus accumbens contributes to the acquisition and maintenance of morphine-induced conditioned place preference

Zhang, X., Cui, Y., Cui, Y., Chen, Y., Na, X.-D., Chen, F., Wei, X., Li, Y.-Y., Liu, X., & Xin, W. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.09.017 · Cited by 80 · see citing works

Recombinant T Cell Receptor Ligand Treats Experimental Stroke

Subramanian, S., Zhang, B., Kosaka, Y., Burrows, G. G., Grafe, M. R., Vandenbark, A. A., Hurn, P. D., & Offner, H. (2009) · Stroke · doi:10.1161/strokeaha.108.543991 · Cited by 79 · see citing works

Granulocyte Function and Levels of Immunoglobulins and Complement in Patients Admitted for Withdrawal from Alcohol

MacGregor, R. R., Gluckman, S. J., & Senior, J. (1978) · The Journal of Infectious Diseases · doi:10.1093/infdis/138.6.747 · Cited by 78 · see citing works

Attenuation of microglial and IL-1 signaling protects mice from acute alcohol-induced sedation and/or motor impairment

Wu, Y. H., Lousberg, E. L., Moldenhauer, L. M., Hayball, J. D., Robertson, S. A., Coller, J. K., Watkins, L. R., Somogyi, A. A., & Hutchinson, M. R. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.01.012 · Cited by 78 · see citing works

Low-Dose Memantine Attenuated Morphine Addictive Behavior Through its Anti-Inflammation and Neurotrophic Effects in Rats

Chen, S., Tao, P., Chu, C., Chen, S., Wu, H.-E., Tseng, L. F., Hong, J., & Lu, R. (2011) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-011-9337-9 · Cited by 76 · see citing works

Individualised treatment in alcohol-dependent patients

Mann, K. F., & Hermann, D. (2010) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-010-0153-7 · Cited by 76 · see citing works

Personalized Treatment of Alcohol Dependence

Kranzler, H. R., & McKay, J. R. (2012) · Current Psychiatry Reports · doi:10.1007/s11920-012-0296-5 · Cited by 72 · see citing works

Mechanistic Implications of the Findings That Opiates and Other Drugs of Abuse Moderate T‐Cell Surface Receptors and Antigenic Markers

Donahoe, R. M., Bueso-Ramos, C., Donahoe, F., MADDEN, J. J., Falek, A., Nicholson, J. K. A., & Bokos, P. J. (1987) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1987.tb35834.x · Cited by 71 · see citing works

Effects of Cognitive Impairment on Substance Abuse Treatment Attendance: Predictive Validation of a Brief Cognitive Screening Measure

Copersino, M. L., Schretlen, D. J., Fitzmaurice, G. M., Lukas, S. E., Faberman, J., Sokoloff, J., & Weiss, R. D. (2012) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2012.670866 · Cited by 70 · see citing works

Naloxone-precipitated morphine withdrawal behavior and brain IL-1β expression: Comparison of different mouse strains

Liu, L., Coller, J. K., Watkins, L. R., Somogyi, A. A., & Hutchinson, M. R. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.03.016 · Cited by 66 · see citing works

Increased Serum IgE in Alcoholics: Relationship With Th1/Th2 Cytokine Production by Stimulated Blood Mononuclear Cells

Domínguez‐Santalla, M. J., Vidal, C., Viñuela, J. E., Perez, L., & González‐Quintela, A. (2001) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2001.tb02336.x · Cited by 66 · see citing works

Vaccines against nicotine

Cerny, E. H., & Cerny, T. (2009) · Human Vaccines · doi:10.4161/hv.5.4.7310 · Cited by 63 · see citing works

Human Neutrophil Functions Are Inhibited In Vitro by Clinically Relevant Ethanol Concentrations

Patel, M., Keshavarzian, A., Kottapalli, V., Badie, B., Winship, D. H., & Fields, J. Z. (1996) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1996.tb01640.x · Cited by 62 · see citing works

Morphine Disrupts Interleukin-23 (IL-23)/IL-17-Mediated Pulmonary Mucosal Host Defense against Streptococcus pneumoniae Infection

Ma, J., Wang, J., Wan, J., Charboneau, R., Chang, Y., Barke, R. A., & Roy, S. (2009) · Infection and Immunity · doi:10.1128/iai.00914-09 · Cited by 62 · see citing works

Suppression of Natural Killer Cell Activity by Ethanol Consumption and Food Restriction

Blank, S. E., Duncan, D. A., & Meadows, G. G. (1991) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1991.tb00514.x · Cited by 62 · see citing works

Differential effects of intermittent or continuous exposure to cocaine on the hypothalamic-pituitary-adrenal axis and c-fos expression

Torres, G., & RIVIER, C. L. (1992) · Brain Research · doi:10.1016/0006-8993(92)90656-t · Cited by 60 · see citing works

Specific Gene Expression and Possible Involvement of Inflammation in Methamphetamine‐Induced Neurotoxicity

Asanuma, M., Miyazaki, I., Higashi, Y., Tsuji, T., & Ogawa, N. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1316.009 · Cited by 60 · see citing works

Morphine Decreases Bacterial Phagocytosis by Inhibiting Actin Polymerization through cAMP-, Rac-1-, and p38 MAPK-Dependent Mechanisms

Ninković, J., & Roy, S. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.11.034 · Cited by 60 · see citing works

Vaccines against stimulants: cocaine and MA

Kosten, T. R., Domingo, C. B., Orson, F. M., & Kinsey, B. M. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12115 · Cited by 58 · see citing works

Temporal changes in innate immune signals in a rat model of alcohol withdrawal in emotional and cardiorespiratory homeostatic nuclei

Freeman, K., Brureau, A., Vadigepalli, R., Staehle, M. M., Morin‐Brureau, M., Gonye, G. E., Hoek, J. B., Hooper, D. C., & Schwaber, J. S. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-97 · Cited by 57 · see citing works

Anti‐drug vaccines to treat substance abuse

Kinsey, B. M., Jackson, D. C., & Orson, F. M. (2009) · Immunology and Cell Biology · doi:10.1038/icb.2009.17 · Cited by 56 · see citing works

Development of active and passive human vaccines to treat methamphetamine addiction

Gentry, W. B., Rüedi‐Bettschen, D., & Owens, S. M. (2009) · Human Vaccines · doi:10.4161/hv.5.4.7456 · Cited by 54 · see citing works

Abrupt or precipitated withdrawal from morphine induces immunosuppression

Rahim, R. T., Adler, M. W., Meissler, J. J., Cowan, A., Rogers, T. J., Geller, E. B., & Eisenstein, T. K. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00103-0 · Cited by 54 · see citing works

Cocaine Infusion Increases Interferon-γ and Decreases Interleukin-10 in Cocaine-Dependent Subjects

Gan, X.-H., Zhang, L., Newton, T. F., Chang, S. L., Ling, W. W., Kermani, V., Berger, O., Graves, M. C., & Fiala, M. (1998) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1998.4607 · Cited by 53 · see citing works

A Promising Therapeutic Approach for Multiple Sclerosis: Recombinant T-Cell Receptor Ligands Modulate Experimental Autoimmune Encephalomyelitis by Reducing Interleukin-17 Production and Inhibiting Migration of Encephalitogenic Cells into the CNS

Sinha, S., Subramanian, S., Proctor, T. M., Kaler, L. J., Grafe, M. R., Dahan, R., Huan, J., Vandenbark, A. A., Burrows, G. G., & Offner, H. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.3599-07.2007 · Cited by 51 · see citing works

Minocycline affects cocaine sensitization in mice

Chen, H., Uz, T., & Manev, H. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.01.078 · Cited by 49 · see citing works

Antigen‐Specific Therapy Promotes Repair of Myelin and Axonal Damage in Established EAE

Wang, C., Gold, B. G., Kaler, L. J., Yu, X., Afentoulis, M. E., Burrows, G. G., Vandenbark, A. A., BOURDETTE, D. N., & Offner, H. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04081.x · Cited by 49 · see citing works

A Combination of Buprenorphine and Naltrexone Blocks Compulsive Cocaine Intake in Rodents Without Producing Dependence

Wee, S., Vendruscolo, L. F., Misra, K., Schlosburg, J. E., & Koob, G. F. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003948 · Cited by 48 · see citing works

The glial cell modulators, ibudilast and its amino analog, AV1013, attenuate methamphetamine locomotor activity and its sensitization in mice

Snider, S. E., Vunck, S. A., van den Oord, E. J. C. G., Adkins, D. E., McClay, J. L., & Beardsley, P. M. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.01.013 · Cited by 45 · see citing works

Ethanol Ingestion Impairs Neutrophil Bactericidal Mechanisms against Streptococcus pneumoniae

Jareo, P. W., Preheim, L. C., & Gentry, M. J. (1996) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1996.tb01711.x · Cited by 45 · see citing works

Methamphetamine enhances Hepatitis C virus replication in human hepatocytes

Ye, L., Peng, J. S., Wang, X., Wang, Y. J., Luo, G. G., & Ho, W. (2008) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2007.00940.x · Cited by 45 · see citing works

Effects of the NK1antagonist, aprepitant, on response to oral and intranasal oxycodone in prescription opioid abusers

WALSH, S. L., Heilig, M. A., Nuzzo, P. A., Henderson, P., & Lofwall, M. R. (2012) · Addiction Biology · doi:10.1111/j.1369-1600.2011.00419.x · Cited by 44 · see citing works

Anti-cocaine vaccine development

Kinsey, B. M., Kosten, T. R., & Orson, F. M. (2010) · Expert Review of Vaccines · doi:10.1586/erv.10.102 · Cited by 42 · see citing works

Enhancement of the hypothalamic–pituitary–adrenal axis but not cytokine responses to stress challenges imposed during withdrawal from acute alcohol exposure in Sprague–Dawley rats

Buck, H. M., Hueston, C. M., Bishop, C., & Terrence Deak, B. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2388-z · Cited by 41 · see citing works

Nicotine vaccines to treat tobacco dependence

Goniewicz, M. L., & Delijewski, M. (2012) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.22060 · Cited by 40 · see citing works

Effects of topiramate on methamphetamine-induced changes in attentional and perceptual-motor skills of cognition in recently abstinent methamphetamine-dependent individuals

Johnson, B. A., Roache, J. D., Ait‐Daoud, N., Wells, L. T., Wallace, C. L., Dawes, M. A., Liu, L., & Wang, X. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.08.002 · Cited by 38 · see citing works

Behavioral actions of alcohol: phenotypic relations from multivariate analysis of mutant mouse data

Blednov, Y. A., Mayfield, R. D., Belknap, J. K., & Harris, R. A. (2012) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2012.00780.x · Cited by 38 · see citing works

Methamphetamine sensitization attenuates the febrile and neuroinflammatory response to a subsequent peripheral immune stimulus

Buchanan, J. B., Sparkman, N. L., & Johnson, R. W. (2009) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2009.12.008 · Cited by 37 · see citing works

A neurotoxic regimen of methamphetamine exacerbates the febrile and neuroinflammatory response to a subsequent peripheral immune stimulus

Buchanan, J. B., Sparkman, N. L., & Johnson, R. W. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-82 · Cited by 35 · see citing works

Stress-Induced Suppression of the Immune System after Withdrawal from Chronic Cocaine

Avila, A. H., Morgan, C. A., & Bayer, B. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.045989 · Cited by 35 · see citing works

Immune, neuroendocrine, and somatic alterations in animal models of human heroin abuse

Weber, R. J., Gomez‐Flores, R., Smith, J. E., & Martin, T. J. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2003.10.029 · Cited by 34 · see citing works

Gender differences in the long‐term outcome of alcohol dependence treatments: An analysis of twenty‐year prospective follow up

Bravo, F., Gual, A., Lligoña, A., & Colom, J. (2012) · Drug and Alcohol Review · doi:10.1111/dar.12023 · Cited by 32 · see citing works

Opioid maintenance therapy restores CD4+ T cell function by normalizing CD4+CD25high regulatory T cell frequencies in heroin user

Riß, G.-L., Chang, D., Wevers, C., Westendorf, A. M., Buer, J., Scherbaum, N., & Hansen, W. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.05.008 · Cited by 28 · see citing works

The use of dopaminergic and stimulant drugs for the treatment of depression.

Howland, R. (2012) · Journal of Psychosocial Nursing and Mental Health Services · doi:10.3928/02793695-20120112-03 · Cited by 28 · see citing works

Serum cytokine concentrations in alcohol-dependent individuals without liver disease

Nicolaou, C., Chatzipanagiotou, S., Tzivos, D., Tzavellas, E., Boufidou, F., & Liappas, I. (2004) · Alcohol · doi:10.1016/j.alcohol.2004.02.004 · Cited by 28 · see citing works

Long‐Term Binge and Escalating Ethanol Exposure Causes Necroinflammation and Fibrosis in Rat Liver

Zhou, J., Jiang, Z., Zhao, C., Zhen, Z., Wang, W., & Nanji, A. A. (2012) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2012.01936.x · Cited by 26 · see citing works

Cocaine Use Reduction with Buprenorphine (CURB): Rationale, design, and methodology

Mooney, L. J., Nielsen, S., Saxon, A. J., Hillhouse, M. P., Thomas, C., Hasson, A. L., Stablein, D. M., McCormack, J., Lindblad, R., & Ling, W. W. (2012) · Contemporary Clinical Trials · doi:10.1016/j.cct.2012.11.002 · Cited by 25 · see citing works

WHO Documents Worldwide Need for Better Drug Abuse Treatment—and Access to It

Kuehn, B. M. (2012) · JAMA · doi:10.1001/jama.2012.8882 · Cited by 25 · see citing works

Inhibition of NF-kappa B binding correlates with increased nuclear glucocorticoid receptor levels in acute alcohol-treated human monocytes.

Mandrekar, P., Bellerose, G., & Szabó, G. (2002) · PubMed · doi:10.1097/01.alc.0000042220.48841.9e · Cited by 23 · see citing works

Phagocytosis and Production of Reactive Oxygen Species by Peripheral Blood Phagocytes in Patients With Different Stages of Alcohol‐Induced Liver Disease: Effect of Acute Exposure to Low Ethanol Concentrations

Parlesak, A., Schäfer, C., Paulus, S., Hammes, S., Diedrich, J. P., & Bode, C. (2003) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000056688.27111.49 · Cited by 21 · see citing works

Immune Changes in Alcohol-Dependent Patients Without Medical Disorders

Schleifer, S. J., Keller, S. E., Shiflett, S. C., Benton, T., & Eckholdt, H. (1999) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1999.tb04278.x · Cited by 21 · see citing works

Acute Oral Ethanol Exposure Triggers Asthma In Cockroach Allergen–Sensitized Mice

Bouchard, J., Kim, J., Beal, D. R., Vaickus, L. J., Craciun, F. L., & Remick, D. G. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.05.020 · Cited by 20 · see citing works

Effects of amphetamine on NK-related cytotoxicity in rats differing in locomotor reactivity and social position

Wrona, D., Sukiennik, L., Jurkowski, M. K., Jurkowlaniec, E., Glac, W., & Tokarski, J. (2004) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2004.04.002 · Cited by 20 · see citing works

ROLE OF NUTRIENTS IN ALCOHOL-INDUCED IMMUNOMODULATION

WATSON, R. R., & Watzl, B. (1993) · Alcohol and Alcoholism · doi:10.1093/oxfordjournals.alcalc.a045352 · Cited by 19 · see citing works

Addressing the Need for Treatment Paradigms for Drug-Abusing Patients with Multiple Morbidities

Kresina, T. F., Normand, J., Khalsa, J. H., Mitty, J. A., Flanigan, T., & Francis, H. L. (2004) · Clinical Infectious Diseases · doi:10.1086/421403 · Cited by 19 · see citing works

Major depression and immunity in alcohol-dependent persons

Schleifer, S. J., Keller, S. E., & Czaja, S. J. (2005) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2005.05.006 · Cited by 18 · see citing works

Partial MHC/Neuroantigen Peptide Constructs: A Potential Neuroimmune-Based Treatment for Methamphetamine Addiction

Loftis, J. M., Wilhelm, C., Vandenbark, A. A., & Huckans, M. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056306 · Cited by 18 · see citing works

Ethanol Exposure Suppresses Bone Marrow-Derived Dendritic Cell Inflammatory Responses Independent of TLR4 Expression

Rendón, J. L., Janda, B. A., Bianco, M. E., & Choudhry, M. A. (2012) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2012.0005 · Cited by 16 · see citing works

Influence and Experimental Alcohol Administration on Serum Immunoglobulin Levels: Contrasting Effects on Ige and other Immunoglobulin Classes

Alonso‐Sampedro, M., Rial, J. G., Gudé, F., Vidal, C., & González‐Quintela, A. (2012) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463201202500311 · Cited by 15 · see citing works

RSA 2004: Combined Basic Research Satellite Symposium-Mechanisms of Alcohol-Mediated Organ and Tissue Damage: Inflammation and Immunity and Alcohol and Mitochondrial Metabolism: At the Crossroads of Life and Death Session One: Alcohol, Cellular and Organ

Thiele, G. M., Mandrekar, P., Zakhari, S., Hoek, J. B., Cook, R. T., Ray, N. B., Happel, K. I., Kolls, J. K., Kovacs, E. J., & Szab, G. (2005) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000179313.64522.56 · Cited by 14 · see citing works

Vulnerability to alcoholic liver disease.

Arria, A. M., Tarter, R. E., & Thiel, D. H. V. (1991) · PubMed · Cited by 14 · see citing works

Tackling Alcoholism With Drugs

Miller, G. (2008) · Science · doi:10.1126/science.320.5873.168 · Cited by 11 · see citing works

Short‐term Administration of Ethanol in Mice Deviates Antigen Presentation Activity Towards B Cells

Andrade, M. C., Albernaz, M. J. S., Araújo, M. S. S., SANTOS, B. P. D. R., Teixeira‐Carvalho, A., Faria, A. M. C., & Martins‐Filho, O. A. (2009) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2009.02289.x · Cited by 11 · see citing works

Cocaine Inhibits Human Neutrophil Phagocytosis and Phagolysosomal AcidificationIn Vitro

Mukunda, B. N., Callahan, J. M., Hobbs, M. S., & West, B. C. (2000) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923970009016426 · Cited by 10 · see citing works

Cytoplasmic Cytokines in the T Cells of Chronic Alcoholics

Cook, R. T. (2000) · Alcoholism Clinical and Experimental Research · doi:10.1097/00000374-200002000-00017 · Cited by 9 · see citing works

Ethanol‐Induced Malfunction of Neutrophils Respiratory Burst on Patients Suffering From Alcohol Dependence

Breitmeier, D., Becker, N., Weilbach, C., Albrecht, K., Scheinichen, D., Panning, B., Schneider, U., & Jüttner, B. (2008) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00748.x · Cited by 9 · see citing works

Toll-Like Receptors Expression and NF-κB Activation in Peritoneal Leukocytes in Morphine-Mediated Impairment of Zymosan-Induced Peritonitis in Swiss Mice

Wypasek, E., Natorska, J., Mazur-Biały, A. I., & Kołaczkowska, E. (2012) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-012-0186-x · Cited by 9 · see citing works

Baclofen for the Treatment of Alcohol Dependence

Howland, R. H. (2012) · Journal of Psychosocial Nursing and Mental Health Services · doi:10.3928/02793695-20120906-92 · Cited by 8 · see citing works

Much ado about nothing.

Ader, R. (2001) · PubMed · Cited by 8 · see citing works

Hematological, immunological and neurochemical effects of chronic amphetamine treatment in male rats

Llorente, E., Abreu-González, P., & González-Hernández, M. C. (2009) · Journal of Physiology and Biochemistry · doi:10.1007/bf03165970 · Cited by 6 · see citing works

Immunoglobulins in chronic alcoholics: relation to liver histology and effect of 2-month abstinence therapy.

Bogdał, J., Cichecka, K., Kirchmayer, S., Mika, M., & Tarnawski, A. S. (1976) · PubMed · Cited by 6 · see citing works

COGNITIVE ENHANCEMENT IN COMBINATION WITH ‘BRAIN REPAIR’ MAY BE OPTIMAL FOR THE TREATMENT OF STIMULANT ADDICTION

Loftis, J. M., & Huckans, M. S. (2011) · Addiction · doi:10.1111/j.1360-0443.2010.03354.x · Cited by 4 · see citing works

[A single administration of morphine suppresses the reduction of the systemic immune activity caused by acute inflammatory pain in rats].

Sakaue, S., Sunagawa, M., Tanigawa, H., Saito, Y., Guo, S., Okada, M., Nakamura, A., Arai, K., & Hisamitsu, T. (2011) · PubMed · Cited by 3 · see citing works

Psychoneuroimmunologic Aspects of Alcohol and Substance Abuse

Schleifer, S. J. (2007) · Elsevier eBooks · doi:10.1016/b978-012088576-3/50032-0 · Cited by 3 · see citing works

Neuroinflammation in addiction: A review of neuroimaging studies and potential immunotherapies

Kohno, M., Link, J., Dennis, L. E., McCready, H. D., Huckans, M. S., Hoffman, W. F., & Loftis, J. M. (2019) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2019.01.007 · Cited by 168 · see citing works

Neuroimmune Basis of Methamphetamine Toxicity

Loftis, J. M., & Janowsky, A. J. (2014) · International review of neurobiology · doi:10.1016/b978-0-12-801284-0.00007-5 · Cited by 121 · see citing works

Covid-19 and Persons with Substance Use Disorders: Inequities and Mitigation Strategies

Melamed, O. C., Hauck, T. S., Buckley, L., Selby, P. L., & Mulsant, B. H. (2020) · Substance Abuse · doi:10.1080/08897077.2020.1784363 · Cited by 112 · see citing works

Tubular human brain organoids to model microglia-mediated neuroinflammation

Ao, Z., Cai, H., Wu, Z., Song, S., Karahan, H., Kim, B., Lu, H.-C., Kim, J., Mackie, K., & Guo, F. (2021) · Lab on a Chip · doi:10.1039/d1lc00030f · Cited by 87 · see citing works

Flagellin as Carrier and Adjuvant in Cocaine Vaccine Development

Lockner, J. W., Eubanks, L. M., Choi, J. L., Lively, J. M., Schlosburg, J. E., Collins, K. C., Globisch, D., Gunn, R. J., Wilson, I. A., & Janda, K. D. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500520r · Cited by 54 · see citing works

Inflammatory Markers in Substance Use and Mood Disorders: A Neuroimaging Perspective

Agarwal, K., Manza, P., Chapman, M., Nawal, N., Biesecker, E., McPherson, K. L., Dennis, E., Johnson, A., Volkow, N. D., & Joseph, P. V. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.863734 · Cited by 51 · see citing works

Circulating cytokine levels are associated with symptoms of depression and anxiety among people with alcohol and drug use disorders

Martínez, P., Lien, L., Zemore, S. E., Bramness, J. G., & Neupane, S. P. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.02.011 · Cited by 50 · see citing works

Plasma Inflammatory Factors Are Associated with Anxiety, Depression, and Cognitive Problems in Adults with and without Methamphetamine Dependence: An Exploratory Protein Array Study

Huckans, M. S., Fuller, B. E., Chalker, A. L. N., Adams, M. K. M., & Loftis, J. M. (2015) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2015.00178 · Cited by 49 · see citing works

Fentanyl self-administration impacts brain immune responses in male Sprague-Dawley rats

Ezeomah, C., Cunningham, K. A., Stutz, S. J., Fox, R. G., Bukreyeva, N., Dineley, K. T., Paessler, S., & Cisneros, I. E. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.03.003 · Cited by 39 · see citing works

Cocaine Vaccine Development: Evaluation of Carrier and Adjuvant Combinations That Activate Multiple Toll-Like Receptors

Kimishima, A., Wenthur, C. J., Eubanks, L. M., Sato, S., & Janda, K. D. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00682 · Cited by 38 · see citing works

Telomere length in psychiatric disorders: Is it more than an ageing marker?

Monroy‐Jaramillo, N., Dyukova, E., & Walss‐Bass, C. (2016) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2016.1273550 · Cited by 37 · see citing works

Altered energy production, lowered antioxidant potential, and inflammatory processes mediate CNS damage associated with abuse of the psychostimulants MDMA and methamphetamine

Downey, L. A., & Loftis, J. M. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.01.032 · Cited by 36 · see citing works

Protein Kinase Cδ Gene Depletion Protects Against Methamphetamine-Induced Impairments in Recognition Memory and ERK1/2 Signaling via Upregulation of Glutathione Peroxidase-1 Gene

Tran, T.-V., Shin, E., Nguyen, L. T. T., Lee, Y., Kim, D.-J., Jeong, J. H., Jang, C., Nah, S.-Y., Toriumi, K., Nabeshima, T., et al. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0638-8 · Cited by 34 · see citing works

Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio in Methamphetamine Use Disorder

Demir, B., Şahin, Ş. K., Özsoy, F., Altındağ, A., & Elboğa, G. (2021) · Psychiatry and Clinical Psychopharmacology · doi:10.5152/pcp.2021.20156 · Cited by 20 · see citing works

Association of miR-155, miR-187 and Inflammatory Cytokines IL-6, IL-10 and TNF-α in Chronic Opium Abusers

Purohit, P., Roy, D., Dwivedi, S., Nebhinani, N., & Sharma, P. (2022) · Inflammation · doi:10.1007/s10753-021-01566-0 · Cited by 19 · see citing works

Plasma pro- and anti-inflammatory cytokines may relate to cocaine use, cognitive functioning, and depressive symptoms in cocaine use disorder

Stamatovich, S. N., Lopez-Gamundi, P., Suchting, R., Colpo, G. D., Walss‐Bass, C., Lane, S. D., Schmitz, J. M., & Wardle, M. C. (2020) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2020.1828439 · Cited by 19 · see citing works

Association of Leukocytosis with Amphetamine and Cocaine Use

Richards, J. R., Farias, V. F., & Clingan, C. S. (2014) · The Scientific World JOURNAL · doi:10.1155/2014/207651 · Cited by 18 · see citing works

Using a Syndemics Framework to Understand How Substance Use Contributes to Morbidity and Mortality among People Living with HIV in Africa: A Call to Action

Peprah, E. K., MYERS, B. J., Kengne, A. P., Peer, N., Shahawy, O. E., Ojo, T., Mukasa, B., Ezechi, O., Iwelunmor, J., Ryan, N., et al. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19031097 · Cited by 17 · see citing works

Exploring cannabidiol effects on inflammatory markers in individuals with cocaine use disorder: a randomized controlled trial

Morissette, F., Mongeau‐Pérusse, V., Rizkallah, É., Thébault, P., Lepage, S. E., Brissette, S., Bruneau, J., Dubreucq, S., Stip, É., Cailhier, J., et al. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-021-01098-z · Cited by 16 · see citing works

Role of Cannabinoid CB2 Receptor in Alcohol Use Disorders: From Animal to Human Studies

García‐Gutiérrez, M. S., Navarrete, F., Gasparyan, A., Navarro, D., Morcuende, Á., Femenía, T., & Manzanares, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23115908 · Cited by 14 · see citing works

Dynamic immune and exosome transcriptomic responses in patients undergoing psychostimulant methamphetamine withdrawal

Wu, H., Zhang, Z., Ma, Y., Chen, F., Xiong, P., Xie, Z., Ding, G., Yu, J., & Wang, K. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.961131 · Cited by 13 · see citing works

Vaccination against cocaine using a modifiable dendrimer nanoparticle platform

Lowell, J. A., Dikici, E., Joshi, P., Landgraf, R., Lemmon, V., Daunert, S., Izenwasser, S., & Daftarian, P. M. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.10.041 · Cited by 12 · see citing works

Calix[n]arene-based immunogens: A new non-proteic strategy for anti-cocaine vaccine

Neto, L. D. S., Maia, A. F. D. S., Godin, A. M., Augusto, P. S. D. A., Pereira, R. L. G., Caligiorne, S. M., Alves, R. B., Fernandes, S. O. A., Cardoso, V. N., Goulart, G. A. C., et al. (2021) · Journal of Advanced Research · doi:10.1016/j.jare.2021.09.003 · Cited by 10 · see citing works

Investigations into the efficacy of multi-component cocaine vaccines

Kimishima, A., Olson, M. E., & Janda, K. D. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.12.043 · Cited by 10 · see citing works

Efficient Syntheses of Cocaine Vaccines and Their in Vivo Evaluation

Kimishima, A., Olson, M. E., Natori, Y., & Janda, K. D. (2018) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.8b00051 · Cited by 10 · see citing works

Premorbid traumatic stress and veteran responses to the COVID‐19 pandemic

Fein‐Schaffer, D., Hawn, S. E., Annunziata, A. J., Ryabchenko, K. A., Miller, M. W., & Wolf, E. J. (2021) · Journal of Traumatic Stress · doi:10.1002/jts.22770 · Cited by 10 · see citing works

Cannabinoid CB2 receptors modulate alcohol induced behavior, and neuro-immune dysregulation in mice

Kibret, B. G., Roberts, A., Kneebone, A., Embaby, S., Fernandez, J., Liu, Q., & Onaivi, E. S. (2023) · Behavioural Brain Research · doi:10.1016/j.bbr.2023.114439 · Cited by 8 · see citing works

Neuroscience and addiction research: current advances and perspectives

Darcq, E., & Kieffer, B. L. (2024) · Journal of Neural Transmission · doi:10.1007/s00702-024-02763-5 · Cited by 8 · see citing works

Opioid Use Disorder: A Desperate Need for Novel Treatments

Fuehrlein, B., & Ross, D. A. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.01.014 · Cited by 7 · see citing works

Getting to Zero: We Can't Do It Without Addressing Substance Use

Jenkins, R. A. (2018) · AIDS Education and Prevention · doi:10.1521/aeap.2018.30.3.225 · Cited by 5 · see citing works

Sex differences in circulating inflammatory mediators as a function of substance use disorder

May, A. C., Burrows, K., Figueroa‐Hall, L. K., Kirlić, N., White, E. J., Smith, R. S., Ekhtiari, H., Paulus, M. P., Savitz, J. B., & Stewart, J. L. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.108610 · Cited by 5 · see citing works

Medications development for substance-use disorders: contextual influences (dis)incentivizing pharmaceutical-industry positioning

Janero, D. R. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.951631 · Cited by 2 · see citing works

CNR2 rs2229579 and COMT Val158Met variants, but not CNR2 rs2501432, IL-17 rs763780 and UCP2 rs659366, contribute to susceptibility to substance use disorder in the Turkish population

Kurnaz, S., Yazıcı, A. B., Nursal, A. F., Aydın, P. Ç., Atar, A. Ö., Aydın, N., Kıncır, Z., & Pehlıvan, S. (2019) · Psychiatry and Clinical Psychopharmacology · doi:10.1080/24750573.2019.1688030 · Cited by 2 · see citing works

Risk assessment of substance use disorders based on the human leukocyte antigen (HLA)

James, L. M., & Georgopoulos, A. P. (2023) · Scientific Reports · doi:10.1038/s41598-023-35305-2 · Cited by 1 · see citing works

Ischemic Stroke Risk Factor Profile at Prof. Dr. W. Z. Johannes Hospital, Kupang, East Nusa Tenggara

Pramanasari, I. (2024) · AKSONA · doi:10.20473/aksona.v4i1.45403 · Cited by 1 · see citing works

Biomarkers in Substance Use Disorder

Lane, S. D., Yoon, J. H., Heads, A. M. B., de Dios, C., Yammine, L., Hong, J. H., Webber, H. E., Weaver, M. F., Schmitz, J. M., & Walss‐Bass, C. (2023) · Springer eBooks · doi:10.1007/978-3-031-43356-6_18 · Cited by 1 · see citing works

Personality and Psychoneuroimmunology: Patient Perspectives on Mind-Body Health

Lee, A., Wong, Y., & Neo, X. S. (2023) · Journal of Personality and Psychosomatic Research · doi:10.61838/kman.jppr.1.3.6 · Cited by 1 · see citing works

LOSS OF CONTROL OVER SUBSTANCE USE

Minnaard, A. M. (2020) · doi:10.33540/163 · Cited by 1 · see citing works

Technology-Assisted Addiction Treatment for Key Populations

Kresina, T. F., Lubran, R., & Clark, H. W. (2014) · Psychology · doi:10.4236/psych.2014.59117

Distinct Plasma Cytokine Levels during Early Abstinence in Amphetamine-Dependent Women with and Without Psychosis

Kuo, S.-C., Yeh, Y., Chen, C. Y., Huang, C. C., Shih, M.-C., Yen, C.-H., Ho, P. S., Liang, C., Tsou, C., Yang, B. Z., et al. (2018) · Neuropsychiatry · doi:10.4172/neuropsychiatry.1000448

Some immunological parameters in abuse substance addicted

Abogelal, A. N. S., & Abd, F. G. (2019) · Journal of Physics Conference Series · doi:10.1088/1742-6596/1294/6/062029

Effect of Naltrexone on Interleukins 2 and 4 in a Sample of Egyptian Patients With Heroin Use Disorder: A Prospective Case-control Study

Mesalhy, O. A. E. A., Ali, O. S. M., ElHabiby, M. M., Hassan, F. A. M., El-Gamel, O. A., & Aufa, O. M. (2021) · Addictive Disorders & Their Treatment · doi:10.1097/adt.0000000000000251

Economic, physical and social determinants of health during the COVID-19 lockdown: a call for renewed societal responses

Lui, L. M. W., Lee, Y. L., & McIntyre, R. S. (2021) · European Respiratory Society eBooks · doi:10.1183/2312508x.10024720

Bidirectional Associations Between Substance Abuse and Psoriasis: A Prospective Cohort Study

Che, X., Zhou, J., Wang, A., Guo, J., Zhang, C., & Xiao, Y. (2026) · Psoriasis Targets and Therapy · doi:10.2147/ptt.s557781

Maternal Mortality Secondary to Maternal Sepsis in Ontario: A Call-to-Action

Malkani, N., Dayo, E., McNaughton-Filion, L., Tunde‐Byass, M., & Barrett, J. (2026) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2026.103210

TNF-dependent regulation of synaptic plasticity and neuronal activity: implications for psychiatric disorders

Moschou, D., Adaïdi, H., & Stellwagen, D. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03861-4

Patients selection in clinical trials with antipsychotics

Hummer, M., Huber, R., Walch, T., & Fleischhacker, W. W. (1996) · European Neuropsychopharmacology · doi:10.1016/0924-977x(96)88237-x

Typical antipsychotics: The threshold doses strategy

Ortega-Soto, H. A., Brunner, E. E., Apiquián, R., de la Torre, M. P., & Ulloa, R. E. (1996) · European Neuropsychopharmacology · doi:10.1016/0924-977x(96)88238-1 · Cited by 3 · see citing works

Neuroimmune mechanisms of psychostimulant and opioid use disorders

Hofford, R. S., Russo, S. J., & Kiraly, D. D. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.14143 · Cited by 92 · see citing works

Neuroimmune modulators as novel pharmacotherapies for substance use disorders

Grodin, E. N. (2024) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2024.100744 · Cited by 3 · see citing works

Neuroimmune Mechanisms as Novel Treatment Targets for Substance Use Disorders and Associated Comorbidities

Namba, M. D., Leyrer-Jackson, J. M., Nagy, E. K., Olive, M. F., & Neisewander, J. L. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.650785 · Cited by 76 · see citing works